FDA Approves Aimmune's (AIMT) Palforzia, Stock Up 17% In After-Hours

The FDA has approved Aimmune Therapeutics Inc.'s (AIMT) Palforzia for the treatment of peanut allergy in patients aged 4 through 17 years.

from RTT - Biotech https://ift.tt/391pXXJ
via IFTTT

Exxon Mobil Q4 Profit Misses View; Chevron Slips To Loss, Yet Tops

Oil major Exxon Mobil Corp. (XOM) Friday reported a 5.2 percent decline in profit for the fourth-quarter quarter from last year, while Chevron Corp. (CVX) posted quarterly loss from a profit a year ago.

from RTT - Earnings https://ift.tt/38Tn3Ez
via IFTTT

Futures Pointing To Initial Pullback On Wall Street

The major U.S. index futures are currently pointing to a lower opening on Friday, with stocks likely to move back to the downside after turning higher over the course of the previous session.

from RTT - Market Analysis https://ift.tt/31bo1cJ
via IFTTT

Gentex Q4 Profit Declines, But Results Beat View - Quick Facts

Gentex Corp. (GNTX), a provider of automotive products, reported Friday that its net income for the fourth quarter declined to $99.5 million or $0.39 per share, from $106.3 million or $0.41 per share in the year-ago period.

from RTT - Earnings https://ift.tt/2S8gQ0G
via IFTTT

Colgate-Palmolive Guides FY20 Net Sales Growth Above Estimates - Quick Facts

While reporting financial results for the fourth quarter on Friday, Colgate-Palmolive Co. (CL) initiated earnings and sales growth guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/2OcY9Yr
via IFTTT

Church & Dwight Sees FY20 Earnings Below Estimates; Hikes Dividend

While reporting its financial results for the fourth quarter on Friday, Church & Dwight Co, Inc. (CHD) provided its financial outlook for the first quarter and fiscal 2020 as well as increased its quarterly dividend by 5 percent.

from RTT - Earnings https://ift.tt/38UNhqb
via IFTTT

IDEXX Laboratories Boosts FY20 Outlook - Quick Facts

While reporting financial results for the fourth quarter on Friday, pet healthcare company IDEXX Laboratories, Inc. (IDXX) raised its earnings and revenue guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/2S4BkYh
via IFTTT

Honeywell Sees FY20 Earnings In Line With Estimates, Sales Below View

While reporting financial results for the fourth quarter, technology company Honeywell international Inc. (HON) on Friday announced its financial outlook for fiscal 2020.

from RTT - Earnings https://ift.tt/2uM738L
via IFTTT

Johnson Controls Reaffirms FY20 Adj. EPS Outlook - Quick Facts

While reporting financial results for the first quarter on Friday, Johnson Controls International plc (JCI) reaffirmed its earnings guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/2RMqDL8
via IFTTT

Electrolux Q4 Profit From Cont. Ops. Declines YoY; Organic Sales Down 2.8%

Electrolux (0MDT.L, 0GQ1.L, ELUXY.PK) reported that its fourth-quarter income for continuing operations amounted to 366 million Swedish kronor compared to 1.24 billion kronor, prior year. Earnings per share from continuing operations was 1.27 kronor compared to 4.30 kronor. Operating income for continuing operations declined 43% year-on-year to 960 million kronor from 1.67 billion kronor, last year. Operating income for Electrolux Professional declined due to lower volumes and transition costs.

from RTT - Earnings https://ift.tt/3aZMBBS
via IFTTT

Vertex Pharma (VRTX) Q4 Results Trounce Estimates, Sees Stronger 2020

Shares of Vertex Pharmaceuticals Inc. (VRTX) were up more than 5 percent in extended trading on Thursday, following strong fourth-quarter and full-year 2019 financial results and rosy outlook.

from RTT - Earnings https://ift.tt/2O8dutx
via IFTTT

Vertex Pharma (VRTX) Q4 Results Trounce Estimates, Sees Stronger 2020

Shares of Vertex Pharmaceuticals Inc. (VRTX) were up more than 5 percent in extended trading on Thursday, following strong fourth-quarter and full-year 2019 financial results and rosy outlook.

from RTT - Biotech https://ift.tt/2O8dutx
via IFTTT

Roper Technologies Guides FY20 Adj. EPS In Line - Quick Facts

While reporting financial results for the fourth quarter on Thursday, Roper Technologies, Inc. (ROP) initiated its adjusted earnings and organic revenue guidance range for the full-year 2020, and provided adjusted earnings outlook for the first quarter.

from RTT - Earnings https://ift.tt/2S555Iv
via IFTTT

Biogen Guides FY20 In Line With Estimates - Quick Facts

While reporting financial results for the fourth quarter on Thursday, Biogen Inc. (BIIB) initiated its earnings, adjusted earnings and revenue guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/2uJyyQg
via IFTTT

Brunswick Narrows FY20 Adj. EPS Outlook Range - Quick Facts

While reporting financial results for the fourth quarter on Thursday, Brunswick Corp. (BC) narrowed its adjusted earnings guidance range for the full-year 2020 to a range of $5.10 to $5.40 per share from the prior forecast range of $5.00 to $5.50 per share. The company also projects net sales growth of 6 to 8 percent.

from RTT - Earnings https://ift.tt/314Pxsa
via IFTTT

AmerisourceBergen Lifts FY20 Earnings Outlook; To Exit PharMEDium Business

While reporting its financial results for the first quarter on Thursday, AmerisourceBergen Corp. (ABC) raised its earnings outlook for fiscal 2020.

from RTT - Earnings https://ift.tt/3aR7zCJ
via IFTTT

Quest Diagnostics Guides FY20 In Line, Boosts Dividend 5.7% - Quick Facts

While reporting financial results for the fourth quarter on Thursday, Quest Diagnostics Inc. (DGX) initiated its earnings and adjusted earnings guidance for the full-year 2020. The company also raised quarterly dividend and share repurchase authorization.

from RTT - Earnings https://ift.tt/2U9vszK
via IFTTT

Corteva Q4 Loss Narrows; Sales Rise - Quick Facts

Corteva, Inc. (CTVA) on Thursday reported fourth-quarter net loss attributable to the company of $21 million or $0.03 per share, narrower than net loss of $531 million or $0.71 per share in the year-ago period.

from RTT - Earnings https://ift.tt/37LzPFa
via IFTTT

Alexion Pharmaceuticals Guides FY20 Below Analysts' Estimates - Quick Facts

While reporting financial results for the fourth quarter on Thursday, Alexion Pharmaceuticals Inc. (ALXN) initiated its earnings and total revenue guidance for the full year 2020, below analysts' expectations.

from RTT - Earnings https://ift.tt/2RF3aeM
via IFTTT

Murphy Oil Falls To Loss In Q4

Murphy Oil Corp. (MUR) Thursday reported a swing to loss in the fourth quarter. The company reported loss attributable to the company of $71.724 million compared to profit attributable of $103.379 million in the prior year. On a per share basis, loss was $0.46, while it recorded earnings of $0.60 in the comparable prior year.

from RTT - Earnings https://ift.tt/2U6prn8
via IFTTT

Enterprise Products Boosts Cash Distribution 2.3%, To Buy Back Shares

While reporting financial results for the fourth quarter on Thursday, Enterprise Products Partners L.P. (EPD) said its management plans to recommend to the board of Enterprise's general partner an increase its cash distribution with respect to the fourth quarter of 2019 by 2.3 percent to $0.4450 per unit.

from RTT - Earnings https://ift.tt/36EmJbh
via IFTTT

WESCO International Guides FY20 In Line With Estimates - Quick Facts

While reporting financial results for the fourth quarter on Thursday, WESCO International, Inc. (WCC) initiated its earnings and sales growth guidance for the full year 2020, in line with analysts' expectations.

from RTT - Earnings https://ift.tt/2uJeCwL
via IFTTT

Deutsche Bank Q4 Loss Widens, Core Bank Revenues Up, Backs View; Stock Up

Deutsche Bank AG reported Thursday a hefty net loss in its fourth quarter, wider than last year, with weak revenues. Core Bank revenues from ongoing core businesses, however, increased with strong performance of Investment Bank and Asset Management segments, and the company reaffirmed its forecast. Shares of the German banking major were gaining around 3 percent in the morning trading.

from RTT - Earnings https://ift.tt/2S2lA8c
via IFTTT

FDA Warns Against Purell Hand Sanitizer Over Claims To Prevent Viruses

The U.S. Food and Drug Administration has issued a warning letter against GOJO Industries Inc. concerning the marketing of its hand sanitizer brand Purell for claims that they can prevent disease from viruses like Ebola, norovirus, and influenza. The agency notified the violations and urged the company to take prompt action to correct them. GOJO said it took immediate action.

from RTT - Biotech https://ift.tt/3aTrNM5
via IFTTT

Renishaw Plc H1 Pretax Profit Falls; Warns On Challenging Trading Conditions

Renishaw plc (RSW.L) on Thursday reported that its statutory profit before tax for the six months ended 31 December 2019 fell to 9.9 million pounds from 61.6 million pounds in the prior year.

from RTT - Earnings https://ift.tt/3aVtUzh
via IFTTT

3i Group Reports NAV Per Share Of 877p At 31 December 2019 - Quick Facts

3i Group PLC (III.L), a private equity and venture capital company, reported that its NAV per share was 877 pence and total return was 10.1 percent for the nine months to 31 December 2019. This represents an increase from NAV per share of 873 pence on 30 September 2019, despite the negative translation effect of the sterling strengthening in the quarter.

from RTT - Earnings https://ift.tt/2GBhDlq
via IFTTT

Unilever FY19 Profit Declines; Underlying Sales Growth At 2.9%

Unilever plc (UN, ULVR.L, UL) reported profit before tax of 8.29 billion euros for full year 2019 compared to 12.36 billion euros, previous year. Earnings per share was 2.14 euros compared to 3.48 euros. Underlying earnings per share was 2.55 euros compared to 2.35 euros.

from RTT - Earnings https://ift.tt/36CtL07
via IFTTT

BT Group 9-month Pre-tax Profit Declines; Maintains FY Outlook - Quick Facts

Telecom company BT Group plc (BT_A.L, BT) reported Thursday that its profit before tax for the nine months to 31 December 2019 declined to 1.91 billion pounds from last year's 2.09 billion pounds. The results were impacted by upfront interest expense associated with IFRS 16 lease liabilities recognized on 1 April 2019.

from RTT - Earnings https://ift.tt/2t97qJU
via IFTTT

AtriCure Hits All-time High, What Next?

Shares of AtriCure Inc. (ATRC), an atrial fibrillation medical device provider, which touched an all-time high of $40.23 in intraday trading yesterday, have gained nearly 24% so far this month.

from RTT - Biotech https://ift.tt/38RCZaw
via IFTTT

H&M Group Q4 Profit Rises; Says Current 2-Month Trading Higher

Swedish retailer Hennes & Mauritz AB or H&M Group (HNNMY.PK, HMRZF.PK, HEN.L) reported Thursday that its fourth-quarter profit after tax rose to 4.21 billion Swedish kronor from 3.54 billion kronor last year. Earnings per share increased to 2.54 kronor from 2.14 kronor a year ago.

from RTT - Earnings https://ift.tt/2U7rLdH
via IFTTT

Stora Enso Q4 Profit Up 73.9% - Quick Facts

Stora Enso Oyj (SEOAY.PK), a Finnish pulp and paper manufacturer, reported that its net profit for the fourth quarter of 2019 grew 73.9 percent to 519 million euros from 299 million euros in the year-ago period.

from RTT - Earnings https://ift.tt/2S5mL6C
via IFTTT

Casio Computer 9-month Profit Up 13.1%; Affirms FY20 Outlook

Casio Computer Co., Ltd. (CSIOF.PK, CSIOY.PK) on Thursday reported that its nine-month profit attributable to owners of parent rose 13.1 percent to 19.20 billion yen from 16.98 billion yen in the prior-year period. Basic earnings per share were 78.76 yen, up from 68.92 yen last year.

from RTT - Earnings https://ift.tt/37DjiTn
via IFTTT

Roche FY19 Net Profit Up 30%; Sees Growth In FY20 Core Earnings, Sales

Swiss drug major Roche Group (RHHBY) reported Thursday that its fiscal 2019 IFRS net income rose 30% to 14.11 billion Swiss francs from last year's 10.87 billion francs, reflecting strong underlying operating results and the base effect of high goodwill impairments in 2018.

from RTT - Earnings https://ift.tt/314jjNX
via IFTTT

CABA Hits New High, IMMP On Watch, SBPH Drops CATALYST

Today's Daily Dose brings you news about Cabaletta Bio's Pemphigus Vulgaris drug candidate, DBV Technologies' stock offering, the progress of Immutep's pipeline and the decision of Spring Bank to halt the development of its HBV drug candidate.

from RTT - Biotech https://ift.tt/3aTl456
via IFTTT

Samsung Q4 Profit Drops 37%

Samsung Electronics Co Ltd (SMSN.L, SSNNF.OB, SSNLF.OB) reported a profit for the fourth-quarter that dropped about 37.24 percent from last year, reflecting continued fall in memory chip prices and weakness in display panels. Quarterly operating profit also declined 33.70 percent from last year, while sales increased about 1.05 percent.

from RTT - Earnings https://ift.tt/38S5xjQ
via IFTTT

Lear Shares Climb More Than 1%

Shares of Lear Corp. are up 1.35 percent in the morning trade on Wednesday, at $127.22. On Tuesday, the stock had closed at $125.53, down 3.6 percent. The automotive technology firm reported fourth-quarter adjusted earnings of $2.64 per share, on sales of $4.8 billion, both coming in better than the consensus estimate.

from RTT - Earnings https://ift.tt/2RCCOK9
via IFTTT

Boeing Shares Climb

Shares of Boeing are rising more than 2 percent in morning trade on Wednesday at $323.76. The stock has been trading in a range of $302.72 and $446.01 in the past 52 weeks. Today, Boeing said it is focused on returning the 737 Max to service safely. The 737 Max aircraft were grounded by airlines worldwide in March last year following two deadly crashes within a short span of five months.

from RTT - Earnings https://ift.tt/2t3UCo2
via IFTTT

Upbeat Earnings News May Generate Initial Buying Interest

The major U.S. index futures are pointing to a higher open on Wednesday, with stocks likely to extend the notable rebound seen in the previous session.

from RTT - Market Analysis https://ift.tt/314oVrj
via IFTTT

United Bankshares Q4 Results Beat Estimates - Quick Facts

United Bankshares, Inc. (UBSI) reported Wednesday that its net income for the fourth quarter of 2019 was $63.3 million or $0.62 per share, compared to earnings of $64.0 million or $0.62 per share in the year-ago period.

from RTT - Earnings https://ift.tt/2GKaiQR
via IFTTT

Boeing Posts Q4 Loss On 737 MAX Grounding, Results Miss View

Boeing Co. (BA) on Wednesday reported a loss for the fourth-quarter, reflecting impacts of the 737 MAX grounding. Quarterly revenues declined 36.8 percent. Adjusted loss per share and revenue for the quarter missed analysts' expectations.

from RTT - Earnings https://ift.tt/318qjcG
via IFTTT

Canadian Pacific Railway Provides FY20 Adj. EPS Growth Outlook - Quick Facts

While reporting financial results for the fourth quarter on Wednesday, Canadian Pacific Railway Ltd. (CP, CP.TO) initiated adjusted earnings growth and revenue ton miles growth guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/3aSrDEU
via IFTTT

Silvergate Capital Q4 Profit Declines - Quick Facts

Silvergate Capital Corp. (SI) on Wednesday reported net income for the fourth quarter of $3.6 million or $0.19 per share, down sharply from $8.0 million or $0.44 per share in the year-ago period.

from RTT - Earnings https://ift.tt/2OafCkx
via IFTTT

Chesapeake Energy Issues Preliminary Q4 Production Results - Quick Facts

Chesapeake Energy Corp. (CHK) said Wednesday that for the fourth quarter, its average estimated oil production on a preliminary basis was in a range of 125,000 to 126,000 barrels or bbls of oil per day, while average estimated fourth-quarter equivalent production was in a range of 476,000 to 478,000 barrels of oil equivalent or boe per day.

from RTT - Earnings https://ift.tt/314ipkl
via IFTTT

Oshkosh Reaffirms FY20 Outlook, Declares Qtly Dividend - Quick Facts

While reporting financial results for the first quarter on Wednesday, Oshkosh Corp. (OSK) reaffirmed its earnings and net sales guidance for the full-year 2020, and declared quarterly cash dividend.

from RTT - Earnings https://ift.tt/36Ab8tJ
via IFTTT

Silicon Laboratories Q4 Profit Declines, Results Miss View - Quick Facts

Silicon Laboratories Inc. (SLAB) on Wednesday reported that its fourth-quarter net income decreased to $9.72 million or $0.22 per share from $15.15 million or $0.35 per share in the prior year.

from RTT - Earnings https://ift.tt/2O9etcM
via IFTTT

Scotts Miracle-Gro Maintains FY20 Outlook - Quick Facts

While reporting financial results for the first quarter on Wednesday, Scotts Miracle-Gro Co. (SMG) maintained its adjusted earnings and sales growth guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/2RAchNy
via IFTTT

Rockwell Automation Reaffirms FY20 Adj. EPS Outlook - Quick Facts

While reporting financial results for the first quarter on Wednesday, Rockwell Automation, Inc. (ROK) reaffirmed its adjusted earnings and sales growth guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/2uDZhxE
via IFTTT

Brinker International Q2 Adj. Earnings Beats Estimates - Quick Facts

Brinker International, Inc. (EAT) on Wednesday reported that its net income for the second quarter of fiscal 2020 decreased to $27.9 million or $0.73 per share from $32.0 million or $0.83 per share in the same period last year.

from RTT - Earnings https://ift.tt/3aKUrPw
via IFTTT

Automatic Data Processing Backs FY20 Adj. EPS Growth Outlook - Quick Facts

While reporting financial results for the second quarter on Wednesday, Automatic Data Processing Inc. (ADP) maintained its earnings and adjusted earnings growth guidance, while trimming annual revenue growth outlook.

from RTT - Earnings https://ift.tt/2GwPhZB
via IFTTT

Avery Dennison Guides FY2020 Adj. Earnings In Line - Quick Facts

While reporting preliminary, unaudited financial results for the fourth quarter on Wednesday, materials science company Avery Dennison Corp. (AVY) initiated its earnings and adjusted earnings guidance range for the full year 2020.

from RTT - Earnings https://ift.tt/37DyKPo
via IFTTT

Textron Issues FY20 Outlook - Quick Facts

While reporting its financial results for the fourth quarter on Wednesday, Textron Inc. (TXT) forecast fiscal 2020 revenues of about $14 billion and earnings per share in a range of $3.50 to $3.70.

from RTT - Earnings https://ift.tt/2U8dGwC
via IFTTT

Dynatrace Boosts FY19 Outlook - Quick Facts

While reporting financial results for the third quarter on Wednesday, software intelligence provider Dynatrace, Inc. (DT) raised its adjusted earnings and revenue guidance for the full-year 2019 and provided outlook for the fourth quarter.

from RTT - Earnings https://ift.tt/2Oaf4uK
via IFTTT

FirstCash Guides Q1 Below View; Boosts Qtly Dividend - Quick Facts

While reporting financial results for the fourth quarter on Wednesday, retail pawn stores operator FirstCash, Inc. (FCFS) initiated earnings and adjusted earnings growth guidance for the full-year 2020. The company also declared a higher quarterly cash dividend and announced a new share repurchase authorization.

from RTT - Earnings https://ift.tt/2uL9x6Y
via IFTTT

Novartis Q4 Net Profit Weak, But Operating Income Up; Sees Growth In FY20

Swiss drug major Novartis AG reported Wednesday that its fourth-quarter net profit declined, while operating income climbed on strong sales growth. Looking ahead, for fiscal 2020, the company expects net sales to grow mid to high-single digit and core operating income to grow high-single to low double digit, both in constant currency.

from RTT - Earnings https://ift.tt/311YNNM
via IFTTT

ARMP Soars, SAVA Awaits Alzheimer's Data, HEPA On The Move, All Eyes On AIMT

Today's Daily Dose brings you news about Armata Pharma's receipt of a strategic investment from Innoviva; Cassava Sciences' near-term catalyst; encouraging data related to Hepion Pharma's NASH drug candidate CRV431 and merger of Conatus Pharma and privately-held Histogen.

from RTT - Biotech https://ift.tt/3aN0CTb
via IFTTT

Starbucks: FY20 Outlook Unchanged Excl. Impact Of Coronavirus - Quick Facts

Starbucks Corp. (SBUX) said the company will update its fiscal 2020 guidance when it can reasonably estimate the impact of the coronavirus. The company has closed more than half of its stores in China. Starbucks expects these circumstances to materially impact its International segment and consolidated results for the second quarter and fiscal 2020.

from RTT - Earnings https://ift.tt/2uHj6Uu
via IFTTT

Bargain Hunting May Lead To Initial Strength On Wall Street

The major U.S. index futures are currently pointing to a higher open on Tuesday, with stocks likely to move back to the upside following the sell-off seen in the previous session.

from RTT - Market Analysis https://ift.tt/37xhoE0
via IFTTT

Lockheed Martin Boosts FY20 Net Sales Outlook - Quick Facts

While reporting financial results for the fourth quarter on Tuesday, Lockheed Martin Corp. (LMT) initiated earnings outlook for the full-year 2020, while boosting annual net sales outlook.

from RTT - Earnings https://ift.tt/2O5vd4N
via IFTTT

FirstBanCorp. Q4 Adj. Earnings Matches Estimates - Quick Facts

First BanCorp. (FBP), the bank holding company for FirstBank Puerto Rico, on Tuesday reported that its fourth-quarter net income attributable to common shareholders declined to $35.78 million or $0.16 per share, from $100.44 million or $0.46 per share in the year-ago period.

from RTT - Earnings https://ift.tt/2GyCVQw
via IFTTT

Pfizer Q4 Adj. Profit Falls, Revenues Down 9%; Issues FY20 Outlook

Pfizer Inc. (PFE) reported that its fourth-quarter adjusted earnings per share declined 13 percent year-over-year to $0.55. On average, 11 analysts polled by Thomson Reuters expected the company to report profit per share of $0.57, for the quarter. Analysts' estimates typically exclude special items. Adjusted income declined 17 percent year-over-year to $3.11 billion.

from RTT - Earnings https://ift.tt/36AHJ2s
via IFTTT

A.O. Smith Guides FY20 Adj. EPS In Line With Estimates - Quick Facts

While reporting financial results for the fourth quarter on Tuesday, A.O. Smith Corp. (AOS) initiated adjusted earnings and sales growth guidance for the full-year 2020, which excludes the potential impact to its businesses from the developing coronavirus originating in China.

from RTT - Earnings https://ift.tt/2RxvW0x
via IFTTT

PolyOne Q4 Adj. Earnings Beats View - Quick Facts

PolyOne Corp. (POL), a provider of specialized polymer materials, on Tuesday reported that its fourth-quarter net income attributable to common shareholders surged to $465.3 million or $6.00 per share from $11.4 million or $0.14 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/38ILKn2
via IFTTT

Pentair Q4 Cont. EPS Increases,Announces Resignation Plan For CFO Mark Borin

Sustainable water solutions provider Pentair plc (PNR) announced increase in fourth quarter earnings per share from continuing operations to $0.61 from $0.54 in the prior year. Adjusted earnings were $0.68 per share.

from RTT - Earnings https://ift.tt/37zq4cZ
via IFTTT

Xerox Guides FY20 Above Estimates - Quick Facts

While reporting financial results for the fourth quarter on Tuesday, workplace technology company Xerox Holdings Corp. (XRX) initiated earnings and adjusted earnings guidance for the full year 2020, consistent with three-year plan, including further earnings per share expansion and revenue trend improvement.

from RTT - Earnings https://ift.tt/3aLkjea
via IFTTT

3M Announces New Global Operating Model; To Cut About 1,500 Jobs - Quick Facts

While reporting its fourth-quarter financial results on Tuesday, 3M Co, (MMM) provided its financial outlook for fiscal 2020 and said it will cut about 1,500 jobs as part of a restructuring.

from RTT - Earnings https://ift.tt/2O6jtPm
via IFTTT

Biotech Stocks Facing FDA Decision In February 2020

February is just around the corner. It's that time to take a look back at some of the top news stories of January and look ahead at what's coming next over the horizon on the regulatory front.

from RTT - Biotech https://ift.tt/2O78N31
via IFTTT

BorgWarner Guides FY20 Net Sales Below Estimates - Quick Facts

While reporting Preliminary financial results for the fourth quarter and fiscal 2019 on Tuesday, technology solutions provider BorgWarner Inc. (BWA) initiated sales guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/38MwSUU
via IFTTT

United Technologies Provide FY20 Outlook For Pratt & Whitney, Collins Aerospace

While reporting financial results for the fourth quarter on Tuesday, United Technologies Corp. (UTX) provided financial outlook for the full-year 2020 for Pratt & Whitney and Collins Aerospace.

from RTT - Earnings https://ift.tt/2uASN2y
via IFTTT

Lear Guides FY20 Sales Above Estimates - Quick Facts

While reporting financial results for the fourth quarter on Tuesday, automotive technology firm Lear Corp. (LEA) initiated its financial outlook for the full-year 2020.

from RTT - Earnings https://ift.tt/37AMvhP
via IFTTT

Philips Stock Dips On Weak Q4 Profit, Mulls Options For Domestic Appliances Unit

Shares of Philips Electronics NV were losing around 3 percent in the morning trading in Amsterdam after the company reported weak profit in its fourth quarter, despite higher sales. For fiscal 2020, the company aims 4 to 6 percent comparable sales growth and adjusted EBITA margin improvement of around 100 basis points. The company said it will review options for the Domestic Appliances unit.

from RTT - Earnings https://ift.tt/37wJyPu
via IFTTT

Inovio Pharma (INO) Has Started The Year Off Right, More To Come?

Shares of clinical-stage DNA vaccine maker Inovio Pharmaceuticals Inc. (INO) have gained more than 60 percent over the last 5 trading days as the deadly Chinese coronavirus outbreak continues to make headlines in the news.

from RTT - Biotech https://ift.tt/2GtFcg3
via IFTTT

XLRN Soars, FDA Approves Triple Combo Pill For Type 2 Diabetes, MGEN On Watch

Today's Daily Dose brings you news about Acceleron Pharma's pulmonary arterial hypertension trial data; FDA approval of Lilly's combination tablet containing three type 2 diabetes medicines in one pill; Merck's DIFICID tablets and oral suspension securing the regulatory nod in the U.S. and miRagen's near-term catalyst.

from RTT - Biotech https://ift.tt/2O5s4BT
via IFTTT

Did You Pay RAPT Attention?

Shares of RAPT Therapeutics Inc. (RAPT) touched a new high of $49.20 in intraday trading on Monday, before closing at $48.86, up 16.31%.

from RTT - Biotech https://ift.tt/2O43ykJ
via IFTTT

Stock To Watch: Arcus Biosciences (RCUS)

Arcus Biosciences Inc. (RCUS), a clinical-stage biopharmaceutical company developing cancer therapies, has a couple of catalysts to watch out for in the coming months.

from RTT - Biotech https://ift.tt/2GqDCeR
via IFTTT

Futures Pointing To Sharply Lower Open On Wall Street

The major U.S. index futures are currently pointing to a sharply lower opening on Monday, with stocks likely to extend the pullback seen over the previous session.

from RTT - Market Analysis https://ift.tt/2RvGJsg
via IFTTT

Alliance Resource Initiates FY20 Outlook, Slashes Cash Distribution

While reporting financial results for the fourth quarter on Monday, Alliance Resource Partners, L.P. (ARLP) initiated financial guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/37zzbKw
via IFTTT

Zai Lab (ZLAB) Hits All-time High: Did You Ride The Rally?

Shares of Zai Lab Limited (ZLAB), which have gained nearly 32 percent so far this month, closed at an all-time high of $54.74 on Friday (Jan.24, 2020).

from RTT - Biotech https://ift.tt/2NZmBg4
via IFTTT

Healthcare IPOs For The Week Ahead

San Francisco, California-based 1Life Healthcare Inc. is a revenue-generating healthcare technology and management services company affiliated with One Medical Group that delivers medical services in-office and virtually.

from RTT - Biotech https://ift.tt/38F4Qub
via IFTTT

Upbeat Earnings News May Generate Initial Buying Interest

The major U.S. index futures are currently pointing to a higher opening on Friday, with stocks likely to move to the upside following the mixed close seen in the previous session.

from RTT - Market Analysis https://ift.tt/2RZ0UOv
via IFTTT

Ericsson Posts Profit In Q4, Sees Higher Costs In FY20; Stock Dips

Swedish telecom equipment maker Ericsson reported Friday a profit in its fourth quarter, compared to loss last year, driven by increased sales. The company further said its North American business experienced a slowdown and that its operating expenses were higher. Going ahead, the company projects increased costs in fiscal 2020 mainly related to 5G development.

from RTT - Earnings https://ift.tt/30Pzezm
via IFTTT

Co-Diagnostics Surges On Coronavirus Test

Shares of Co-Diagnostics Inc. (CODX) are up over 79%, following news that the Company has completed the principle design work for a PCR screening test for new coronavirus, 2019-nCoV, intended to address potential need for detection of the virus.

from RTT - Biotech https://ift.tt/2TQ2QLG
via IFTTT

Lingering Worries About Coronavirus Outbreak May Generate Selling Pressure

The major U.S. index futures are pointing to a modestly lower opening on Thursday following the lackluster performance seen over the course of the previous session.

from RTT - Market Analysis https://ift.tt/38z8i9L
via IFTTT

Kimberly-Clark Guides FY20 Adj. EPS In Line - Quick Facts

While reporting financial results for the fourth quarter on Thursday, consumer products firm Kimberly-Clark Corp. (KMB) initiated adjusted earnings and sales growth guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/2tArF3C
via IFTTT

Webster Q4 Profit Declines; Elects CEO John Ciulla As Chairman - Quick Facts

Webster Financial Corp. (WBS), the holding company for Webster Bank, N.A. and its HSA Bank division, reported a decline in profit for the fourth quarter from last year.

from RTT - Earnings https://ift.tt/3aBQjBy
via IFTTT

Procter & Gamble Q2 Profit Tops Estimates; Organic Sales Up 5%

The Procter & Gamble Company (PG) reported that its second-quarter core earnings per share rose 14 percent year-on-year, due to lower non-core restructuring charges versus the prior year. Currency-neutral core earnings per share increased 15 percent. Organic sales were up five percent, for the quarter. For fiscal 2020, the company raised its guidance for core earnings per share growth from a range of five to ten percent to a range of eight to eleven percent. Also, the company increased its guidance for organic sales growth from a range of three to five percent to a range of four to five percent.

from RTT - Earnings https://ift.tt/2uqygxo
via IFTTT

JetBlue Airways Guides FY20 Above Estimates - Quick Facts

While reporting financial results for the fourth quarter on Thursday, JetBlue Airways Corp. (JBLU) provided its financial outlook for the first quarter and the full-year 2020.

from RTT - Earnings https://ift.tt/2NQ2bWQ
via IFTTT

VF Corp. Lowers FY20 Outlook - Quick Facts

While reporting its financial results for the third quarter on Thursday, VF Corp. (VFC) lowered its financial outlook for fiscal 2020.

from RTT - Earnings https://ift.tt/36mQRYo
via IFTTT

MarineMax Boosts FY20 0utlook As Q1 Results Top Estimates - Quick Facts

Recreational boat and yacht retailer MarineMax Inc. (HZO) reported Thursday that net income for the first quarter nearly doubled to $9.1 million or $0.41 per share from $4.9 million or $0.21 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/2TPFFkE
via IFTTT

Applied Industrial Trims FY20 Outlook Range, Boosts Dividend - Quick Facts

While reporting financial results for the second quarter of fiscal 2020 on Thursday, Applied Industrial Technologies Inc. (AIT) trimmed the top end of its adjusted earnings and net sales growth guidance range for the full-year 2020, following year to date performance and ongoing end-market uncertainty.

from RTT - Earnings https://ift.tt/30NiSXX
via IFTTT

Five Star Food Recalls Sham Gardens Excellent Tahina For Salmonella Fears

Five Star Food Inc. is recalling certain Sham Gardens Excellent tahina containers for potential contamination with Salmonella, the US Food and Drug Administration said in a statement. The recall involves 100 cases of Excellent tahina 800 g and 100 cases of Excellent tahina 400 g containers. The Garden City, Michigan-based company, however, has not received any reports of illness.

from RTT - Biotech https://ift.tt/3aELGX9
via IFTTT

STMicroelectronics Q4 Profit, Revenues Top View; Sees Q1 Revenues Above Market

Semiconductor company STMicroelectronics NV reported Thursday lower profit in its fourth quarter with weak margin, despite higher revenues. Earnings per share and revenues were above market estimates. Looking ahead for the first quarter, the company projects higher revenues above analysts' estimates. In pre-market activity on the NYSE, STM shares were gaining around 5.6 percent.

from RTT - Earnings https://ift.tt/2RVp5gL
via IFTTT

CNCE Hits Right Notes, BXRX Faces FDA In Feb., All Eyes On AGTC

Today's Daily Dose brings you news about Akcea's promising trial results of antisense drug AKCEA-APOCIII-LRx, Applied Genetic's upcoming event, the near-term catalyst of Baudax Bio and Sierra Oncology's reverse stock split.

from RTT - Biotech https://ift.tt/36fB0ep
via IFTTT

Earnings News, Efforts To Contain Virus May Generate Buying Interest

The major U.S. index futures are pointing to a higher open on Wednesday, with stocks likely to move back to the upside following the modest pullback seen in the previous session.

from RTT - Market Analysis https://ift.tt/2RkTCFH
via IFTTT

Prologis Guides FY20 EPS Above Estimates - Quick Facts

While reporting its financial results for the fourth quarter on Wednesday, Prologis Inc. (PLD) initiated its fiscal 2020 outlook for earnings as well as core funds from operations.

from RTT - Earnings https://ift.tt/37j1ugk
via IFTTT

Abbott Laboratories Guides FY20 Adj. EPS In Line - Quick Facts

While reporting its financial results for the fourth quarter on Wednesday, Abbott Laboratories (ABT) initiated earnings and organic sales growth guidance for the full-year 2020. The company also provided outlook for the first quarter of fiscal 2020.

from RTT - Earnings https://ift.tt/2NNd0J0
via IFTTT

Baker Hughes Q4 Adj. EPS, Revenue Miss View - Quick Facts

Baker Hughes Co. (BKR) on Wednesday reported fourth-quarter net income attributable to the company of $48 million, down 63 percent from $131 million in the year-ago period. Earnings attributable to Class A shareholders fell to $0.07 from $0.28 in the year-ago period.

from RTT - Earnings https://ift.tt/38whPyw
via IFTTT

Johnson & Johnson Q4 Profit Beats Estimates; Adj. Operational Sales Up 3.4%

Johnson & Johnson (JNJ) reported that its fourth-quarter adjusted earnings per share declined 4.6 percent year-on-year. Sales improved 3.4 percent on an adjusted operational basis. Looking forward, Johnson & Johnson said it anticipates continued sales and earnings growth in 2020, with an adjusted operational earnings per share growth in a range of 3.7 percent to 5.4 percent, and an adjusted operational sales growth in a range of 5.0 percent to 6.0 percent.

from RTT - Earnings https://ift.tt/2RfBUmQ
via IFTTT

Rogers Communications Initiates FY20 Revenue Growth Guidance - Quick Facts

While reporting financial results for the fourth quarter on Wednesday, Canadian technology and media company Rogers Communications Inc. (RCI, RCI.TO) provided total service revenue growth guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/2sR7EW2
via IFTTT

CRH Medical (CRHM) Hits New High, Up 18% In A Month

Shares of CRH Medical Corp. (CRHM) hit a new 52-week high of $4.15 on Tuesday, representing a gain of nearly 18% in the last 1 month.

from RTT - Biotech https://ift.tt/2NR2YGR
via IFTTT

Frequency Therapeutics Making The Right Noises, IPO Lockup Expires On Mar.31

Shares of Frequency Therapeutics Inc. (FREQ) which closed at a new high of $26, have gained 50 percent over the last 1 month.

from RTT - Biotech https://ift.tt/2TKLlfC
via IFTTT

First Drug For TED Secures Approval, TROV On Watch, EVOK Faces FDA In June

Today's Daily Dose brings you news about the update on Evoke Pharma's resubmitted New Drug Application for Gimoti; FDA's Fast Track Designation for Genprex' investigational immunogene therapy Oncoprex and Horizon Therapeutics securing FDA approval of TEPEZZA for the treatment of Thyroid Eye Disease, among others.

from RTT - Biotech https://ift.tt/37jkIm6
via IFTTT

Coronavirus Outbreak May Lead To Pullback On Wall Street

The major U.S. index futures are currently pointing to a lower opening on Tuesday, with stocks likely to give back ground following last week's rally to new record highs amid news of a deadly coronavirus outbreak in China.

from RTT - Market Analysis https://ift.tt/2RbVtMJ
via IFTTT

Comerica Issues FY20 Outlook - Quick Facts

While reporting its financial results for the fourth quarter on Tuesday, Comerica Inc. (CMA) provided its financial outlook for fiscal 2020.

from RTT - Earnings https://ift.tt/2NMLZFx
via IFTTT

UBS Q4 Profit Climbs, But FY19 Profit Weak; Cuts Targets; Stock Dips

Swiss banking giant UBS Group AG reported Tuesday significantly higher profit in its fourth quarter, and its best fourth-quarter adjusted profit before tax since 2010. Meanwhile, fiscal 2019 profit declined and the company trimmed its mid-term targets. UBS announced an agreement to sell a 51.2 percent stake in UBS Fondcenter to Clearstream. UBS' shares were losing around 5 percent in Swiss trading

from RTT - Earnings https://ift.tt/37efcRH
via IFTTT

Novavax (NVAX) Gains Over 46% In 5 Days, To Report Phase 3 NanoFlu Data In Q1

Shares of Novavax Inc. (NVAX) have gained more than 46% over the last 5 trading days, thanks to positive development related to its NanoFlu vaccine.

from RTT - Biotech https://ift.tt/36cwlK9
via IFTTT

What Awaits Epizyme (EPZM), Aimmune Therapeutics (AIMT) This Week?

Shares of Epizyme Inc. (EPZM) have gained nearly 10 percent over the last 1 week as the Company awaits the FDA decision on its New Drug Application for Tazemetostat, slated to be announced on January 23, 2020.

from RTT - Biotech https://ift.tt/2ugSOIE
via IFTTT

Anglo American agrees £405m takeover deal for Sirius Minerals

Agreement rescues plans to dig the UK’s first deep mine in 40 years in the North York Moors

The mining company Anglo American has agreed to buy Sirius Minerals for £405m in a deal that rescues plans to dig the UK’s first deep mine in 40 years under the North York Moors.

The pair revealed this month they were in advanced talks over a deal that would hand the struggling fertiliser miner to Anglo for a price of 5.5p a share, which valued the company at £386m.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/38qH0SK

Forty Seven (FTSV) On A Roll, Up Over 300% In 2 Months

Shares of Forty Seven Inc. (FTSV) have been on a roll ever since the Company presented updated clinical data from its ongoing phase Ib trial evaluating Magrolimab in combination with Azacitidine for the treatment of myelodysplastic syndrome and acute myeloid leukemia last December.

from RTT - Biotech https://ift.tt/2NK3o1H
via IFTTT

Bellicum Pharma (BLCM) Up 140% In A Month, To Report BPX-601 Data On Jan.24

Shares of Bellicum Pharmaceuticals Inc. (BLCM) have gained more than 140% over the last 1 month as the Company gears up to present new data related to its autologous GoCAR-T product candidate BPX-601.

from RTT - Biotech https://ift.tt/2RypgOy
via IFTTT

Gold Futures Settle Notably Higher

Gold prices surged higher on Friday amid doubts the signing of the phase one U.S.-China trade agreement may not resolve certain core differences.

from RTT - Market Analysis https://ift.tt/2Tyf7nR
via IFTTT

Cardinal Health To Recall Certain Level 3 Surgical Gowns

Medical device manufacturer Cardinal Health will soon recall certain Level 3 surgical gowns or PreSource procedural packs that contain these gowns following warning that they may not be sterile, the U.S. Food and Drug Administration said in a statement. The health regulator said it is working with the company to find out the specific product lots that are impacted.

from RTT - Biotech https://ift.tt/2TxEsy9
via IFTTT

Perpetual Rally Seems Poised To Continue

The major U.S. index futures are currently pointing to a higher opening on Friday, with stocks likely to extend the rally seen over the course of the previous session.

from RTT - Market Analysis https://ift.tt/2G0eFXm
via IFTTT

Fastenal Q4 Profit Rises, Meets View - Quick Facts

Fastenal Co. (FAST) on Friday reported a 5.9 percent increase in net earnings for the fourth quarter to $178.7 million from $168.8 million in the year-ago period. Earnings per share increased 5.4 percent to $0.31 from $0.29 last year.

from RTT - Earnings https://ift.tt/30uGSyT
via IFTTT

Regions Financial Q4 Profit Declines, Revenue Rises - Quick Facts

Regions Financial Corp. (RF) on Friday reported fourth-quarter net income available to common shareholders of $366 million or $0.38 per share, compared to $390 million or $0.37 per share in the year-ago period.

from RTT - Earnings https://ift.tt/2Ty0vF5
via IFTTT

Will Vir Biotech (VIR) Experience Better Fortune In 2020?

Vir Biotechnology Inc. (VIR), which had a lackluster reception to its initial public offering, has gained 35 percent over the last 5 trading days but is still trading below its offering price of $20 per share.

from RTT - Biotech https://ift.tt/2Tvitba
via IFTTT

Viela Bio (VIE) Hits Record High, Faces FDA In June

Shares of Viela Bio Inc. (VIE), which have been hitting new highs, are up a whopping 100% since the Company's market debut on October 3, 2019.

from RTT - Biotech https://ift.tt/2uZWhff
via IFTTT

Lannett (LCI) Gains 20% In 5 Days - What's The Buzz?

Shares of Lannett Company Inc. (LCI) have gained more than 20 percent over the last five trading days.

from RTT - Biotech https://ift.tt/30zjW1B
via IFTTT

FDA Panel Split On DURECT's Drug, Intellipharma Plunges, BNTX To Acquire NTGN

Today's Daily Dose brings you news about the FDA panel's split verdict on DURECT's postoperative nonopioid pain relief depot, BioNTech's acquisition of Neon Therapeutics and the FDA designating Envafolimab as an orphan drug for the treatment of biliary tract cancer.

from RTT - Biotech https://ift.tt/30sINEc
via IFTTT

Upward Momentum Persists After Trade Deal Signing

The major U.S. index futures are pointing to a higher opening on Thursday, with stocks poised to add to the modest gains posted in the previous session.

from RTT - Market Analysis https://ift.tt/2NxksrP
via IFTTT

Morgan Stanley Q4 Results Top Estimates - Quick Facts

Morgan Stanley (MS) on Thursday reported fourth-quarter net income applicable to the company's shareholders of $2.09 billion or $1.30 per share, up sharply from $1.36 billion or $0.80 per share in the year-ago quarter.

from RTT - Earnings https://ift.tt/370HKhc
via IFTTT

Momenta Pharma (MNTA) Up Over 60% In A Month, Key Data Readouts In 2020

Shares of Momenta Pharmaceuticals Inc. (MNTA) are up nearly 63 percent over the last one month as the Company approaches key data readouts across its clinical programs.

from RTT - Biotech https://ift.tt/2RnHLFp
via IFTTT

RAPT Therapeutics Gains 29% In 5 Days, FLX475 Phase 2 Data Due In Q2

Shares of RAPT Therapeutics Inc. (RAPT) have gained nearly 29 percent over the last five trading days as the Company gears up for some near-term clinical milestones.

from RTT - Biotech https://ift.tt/30o4RQm
via IFTTT

KALA Strides, NKTR Plunges, RMTI In Deal With Sun Pharma, DRRX Faces FDA Panel

Today's Daily Dose brings you news about Kala Pharma's completion of enrollment in STRIDE 3 trial, Rockwell Medical's license and supply agreements with India-based Sun Pharmaceutical and upcoming regulatory catalyst of DURECT.

from RTT - Biotech https://ift.tt/2RrpEi6
via IFTTT

Choppy Trading May Persists Amid Uncertainty About Trade Deal

The major U.S. index futures are pointing to a roughly flat open on Wednesday, with stocks likely to extend the lackluster performance seen in the previous session.

from RTT - Market Analysis https://ift.tt/3afEf8D
via IFTTT

Goldman Sachs Q4 Profit Misses View, But Revenue Beats

Goldman Sachs Group Inc. (GS) reported a profit for the fourth-quarter that declined 26 percent from last year, reflecting higher operating costs. But, net revenues rose 23% due to higher net revenues in Asset Management and Global Markets. Quarterly earnings per share missed analysts' expectations, while revenues beat their estimates.

from RTT - Earnings https://ift.tt/2Rn7yOd
via IFTTT

BlackRock Q4 Results Top Estimates - Quick Facts

BlackRock, Inc. (BLK) reported that its fourth-quarter net income surged to $1.30 billion or $8.29 per share from $927 million or $5.78 per share in the year-ago quarter. Adjusted net income per share was $8.34, compared to last year's $6.08.

from RTT - Earnings https://ift.tt/36WJ0SE
via IFTTT

Citigroup Q4 Net Income Rises; Revenue Up 7%

Citigroup Inc. (C) reported that its fourth-quarter net income increased 15 percent year-on-year driven by the higher revenues and a lower effective tax rate, partially offset by higher expenses and cost of credit. Revenues increased 7 percent, with strong results across both the Institutional Clients Group and Global Consumer Banking.

from RTT - Earnings https://ift.tt/3aarBYL
via IFTTT

Mixed Earnings News May Lead To Choppy Trading On Wall Street

The major U.S. index futures are currently pointing to a roughly flat open on Tuesday, with stocks likely to show a lack of direction after moving notably higher in over the course of the previous session.

from RTT - Market Analysis https://ift.tt/2ToKi54
via IFTTT

Delta Air Lines Backs FY20 EPS Outlook - Quick Facts

While reporting financial results for the fourth quarter on Wednesday, Delta Air Lines (DAL) maintained its earnings guidance for the full-year 2020 and provided revenue growth outlook for the first quarter of fiscal 2020.

from RTT - Earnings https://ift.tt/389hLoe
via IFTTT

Build-A-Bear Workshop Raises FY19 Outlook - Quick Facts

Build-A-Bear Workshop, Inc. (BBW) on Tuesday raised its financial outlook for fiscal 2019, saying it believes to have benefited from its gift giving programs including stronger gift card sales leading to higher redemption rates post-holiday.

from RTT - Earnings https://ift.tt/2QPTE8a
via IFTTT

Futures Pointing To Initial Strength On Wall Street

The major U.S. index futures are currently pointing to a higher opening on Monday, with stocks likely to move back to the upside following the pullback seen over the course of last Friday's trading.

from RTT - Market Analysis https://ift.tt/2TiNVcD
via IFTTT

Taro Pharma Recalls Certain Lot Of Lamotrigine Tablets

Taro Pharmaceuticals U.S.A., Inc., the U.S.-based business of Israeli Pharma firm Taro Pharmaceutical Industries, Ltd., recalled a certain lot of epilepsy and bipolar disorder medication Lamotrigine in the form of tablets for the potential cross-contamination, the U.S. Food and Drug Administration revealed.

from RTT - Biotech https://ift.tt/2TgEOJr
via IFTTT

Big Day Awaits Verona Pharma (VRNA) On Monday

Verona Pharma plc (VRNA) is all set to announce results from its phase IIb dose-ranging study evaluating nebulized Ensifentrine as an add-on to treatment with a long-acting bronchodilator in patients with moderate-to-severe chronic obstructive pulmonary disease on Monday, January 13, 2020, at 5.00 am GMT.

from RTT - Biotech https://ift.tt/39XFHMJ
via IFTTT

Just Eat shareholders approve £6.3bn merger with Dutch firm

‘Dream combination’ with Takeaway.com creates one of world’s largest food delivery groups

Shareholders in Just Eat have given the green light to a £6.3bn merger with Dutch food delivery firm Takeaway.com, which will create one of the largest food delivery groups in the world.

Takeaway.com said Just Eat shareholders holding 80.4% of the company’s voting rights had accepted its all-share merger offer, which it upped to 916p a share just before Christmas.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2scvJWZ

Irrepressible Optimism May Prevail On Wall Street

The major U.S. index futures are currently pointing to a higher opening on Friday, with stocks likely to extend the upward move seen over the course of the previous session.

from RTT - Market Analysis https://ift.tt/30iJe49
via IFTTT

Infosys Raises FY20 Revenue Guidance; Q3 Digital Revenues Up 40.8%

Infosys Limited (INFY), a global leader in next-generation digital services and consulting, increased its fiscal 2020 revenue guidance to a range of 10.0%-10.5% in constant currency. The company maintained its operating margin guidance range of 21%-23%.

from RTT - Earnings https://ift.tt/2tQCSfR
via IFTTT

China-based I-Mab To Make U.S. Trading Debut Next Week

I-Mab is a clinical stage biopharmaceutical company developing novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders.

from RTT - Biotech https://ift.tt/37QVoDz
via IFTTT

Atreca - Catching It Early

Shares of biopharmaceutical company Atreca Inc. (BCEL) have gained 13 percent over the last one month as the Company advances its drug candidate into clinical testing.

from RTT - Biotech https://ift.tt/2tKLvsq
via IFTTT

AGTC Catches Eyes, PTLA Bleeds As Antidote Sales Disappoint, RARE Jumps

Today's Daily Dose brings you news about Applied Genetic's X-linked retinitis pigmentosa trial results, FDA approval of the first targeted therapy to treat a rare mutation in patients with gastrointestinal stromal tumors and DBV Tech's long-term data from phase III open-label extension study of Viaskin Peanut, among others.

from RTT - Biotech https://ift.tt/2FBkL0o
via IFTTT

Mylan Recalls Certain Lots Of Nizatidine Capsules

Mylan Pharmaceuticals, the U.S.-based business of Mylan N.V., recalled certain lots of ulcer medication Nizatidine in the form of capsules for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA). Trace amounts of the impurity was found in the Active Pharmaceutical Ingredient (API) manufactured by India-based Solara Active Pharma Sciences Ltd.

from RTT - Biotech https://ift.tt/304nmJv
via IFTTT

Fulcrum Therapeutics (FULC) Up 65% In A Month, IPO Lockup Expires On Jan.14

Shares of Fulcrum Therapeutics Inc. (FULC) have gained 65 percent over the last one month as the Company progresses with its lead drug candidate Losmapimod in facioscapulohumeral dystrophy.

from RTT - Biotech https://ift.tt/2t2GgnT
via IFTTT

Applied Therapeutics' (APLT) Action-packed Journey From $10 To $40 In 4 Months

Shares of Applied Therapeutics Inc. (APLT) touched an all-time high of $40.14 in intraday trading on Wednesday, a gain of over 50% from the previous day's close, thanks to the Company's positive phase II Galactosemia study results.

from RTT - Biotech https://ift.tt/2N8mwGa
via IFTTT

FDA Nod For MRK, All Eyes On AGTC, ACTION Boosts APLT

Today's Daily Dose brings you news about Applied Therapeutics' ACTION-Galactosemia trial results, FDA approval of Merck's Keytruda for yet another indication, Verastem's a global licensing agreement with Chugai Pharma and SCYNEXIS' FURI study results.

from RTT - Biotech https://ift.tt/2TchMU9
via IFTTT

Amid the fury and bombast, Ghosn’s case deserves proper examination

The former Renault-Nissan boss’s account of why he fled Japan will – and should – provoke sympathy

Carlos Ghosn, live from Lebanon, put on an entertaining show. There was bombast, arm-waving and undisguised fury. “My unimaginable ordeal is the result of a handful of unscrupulous, vindictive individuals,” said the former Renault-Nissan chairman, naming half a dozen Nissan executives whom he alleges plotted his downfall and arrest in Tokyo. Naturally, Ghosn wouldn’t address the most intriguing detail of how he managed to jump bail and board a private jet out of Japan. He may never provide the details.

He did, however, say this: “You can expect me to take some initiative to tell you how I’m going to clear my name, what kind of forum I’m going to use.” And also this: “I am ready to stand trial anywhere that will give me a fair trial.” Both are important promises because this extraordinary case deserves to be examined properly somewhere.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/37L16Hd

Futures Recover From Overnight Weakness, Pointing To Higher Open

The major U.S. index futures are pointing to a modestly higher opening on Wednesday after coming under pressure overnight.

from RTT - Market Analysis https://ift.tt/35v7TmJ
via IFTTT

Constellation Brands Raises Earnings, Cash Flow Guidance; Stock Surges

Constellation Brands, Inc. (STZ) increased its fiscal 2020 comparable basis earnings per share outlook to $9.45 - $9.55. Analysts polled by Thomson Reuters expect the company to report profit per share of $8.51. Analysts' estimates typically exclude special items.

from RTT - Earnings https://ift.tt/2s3YuVC
via IFTTT

Walgreens Boots Alliance Maintains FY20 Outlook - Quick Facts

While reporting financial results for the first quarter of fiscal 2020 on Wednesday, Walgreens Boots Alliance, Inc. (WBA) maintained its adjusted earnings guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/301nXeO
via IFTTT

MSC Industrial Guides Q2 Outlook Below View - Quick Facts

While reporting financial results for the first quarter of fiscal 2020 on Wednesday, MSC Industrial Supply Co. (MSM) provided earnings and sales outlook for the second quarter.

from RTT - Earnings https://ift.tt/2Nm3XyL
via IFTTT

Anglo American mulls £386m rescue bid for Sirius Minerals

Fertiliser miner struggling to fund plans to extract polyhalite from under North York Moors

The mining company Anglo American could rescue plans to dig the UK’s first deep mine in 40 years under the North York Moors through a £386m takeover bid for Sirius Minerals.

The businesses are in advanced talks over a bid that would save Sirius from collapse after the struggling fertiliser miner failed to raise funds for its Yorkshire mine project.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2sZc2SH

Lennar Corp. Issues FY20 Guidance - Quick Facts

Lennar Corp. (LEN) said, for fiscal 2020, the company expects deliveries to be in the range of 54,000 - 55,000 homes, and homebuilding gross margin percentage to be in the range of 20.5% - 21.0%. With only $600 million of senior notes due in 2020, the company plans to opportunistically deploy excess cash flow to repurchase additional debt and return capital to shareholders.

from RTT - Earnings https://ift.tt/35AI8BI
via IFTTT

Keep An Eye On AGTC, Stock Up Over 40% In A Month

Shares of Applied Genetic Technologies Corp. (AGTC) have returned nearly 49 percent over the last one month as the Company gears up to report additional results from X-linked retinitis pigmentosa (XLRP) and achromatopsia trial results this month.

from RTT - Biotech https://ift.tt/37RP1QJ
via IFTTT

Prevail Therapeutics (PRVL) Up Over 75% In 3 Months, What's Ahead?

Shares of Prevail Therapeutics Inc. (PRVL) have gained more than 75% over the last three months, thanks to the progress on its pipeline of AAV-based gene therapies for patients with neurodegenerative disorders.

from RTT - Biotech https://ift.tt/37PkdzJ
via IFTTT

APLS Soars On PNH Data, ADXS On Track, TYME In Deal With Eagle, CVM On Watch

Today's Daily Dose brings you news about Apellis Pharma's PEGASUS study results; Advaxis' progress with ADXS-504 in prostate cancer; CEL-SCI Corp's stock offering and Tyme's strategic collaboration with Eagle Pharma.

from RTT - Biotech https://ift.tt/37JsHbH
via IFTTT

Easing Concerns About U.S.-Iran Tensions May Spark Buying Interest

The major U.S. index futures are currently pointing to a modestly higher open on Tuesday, with stocks likely to extend the upward move seen over the course of the previous session.

from RTT - Market Analysis https://ift.tt/2tFElpy
via IFTTT

BioNTech (BNTX) Is Up 170% In 3 Months, Busy Year Ahead

The American depositary shares of BioNTech SE (BNTX), which made market debut as recently as October 10, 2019, are up an impressive 170 percent based on yesterday's closing price of $44.58.

from RTT - Biotech https://ift.tt/2QwesS3
via IFTTT

Aridis Pharma Up Over 30% In 3 Trading Days, Awaits Phase 3 Data In Early 2020

Aridis Pharmaceuticals Inc. (ARDS), which has gained more than 30% so far this month, has a couple of clinical trial catalysts to watch out for in 2020.

from RTT - Biotech https://ift.tt/2T0irHW
via IFTTT

LIFE Gets A Boost With Kyorin Deal, XERS Up 20% After-Hrs, ITCI On Watch

Today's Daily Dose brings you news about Xeris Pharma's trial results of ready-to-use (RTU) glucagon for the prevention of exercise-induced hypoglycemia; Merck's Keytruda trial results in patients with extensive-stage small-cell lung cancer; collaboration and license agreement between aTyr Pharma and Kyorin Pharmaceutical.

from RTT - Biotech https://ift.tt/2FpTH3R
via IFTTT

Futures Pointing To Continued Weakness On Wall Street

The major U.S. index futures are currently pointing to a lower opening on Monday, with stocks likely to extend the notable pullback seen last Friday.

from RTT - Market Analysis https://ift.tt/37GaEDe
via IFTTT

Milestone Pharma (MIST) Getting Ready For Rhythm Of NODE-301

Shares of Milestone Pharmaceuticals Inc. (MIST) are up nearly 13% over the last six trading days as the Company gears up for clinical data readout in the middle of the first half of 2020.

from RTT - Biotech https://ift.tt/2QOt4uW
via IFTTT

Will Trevi Therapeutics (TRVI) Take Off After Dismal 2019?

Trevi Therapeutics Inc. (TRVI), whose share performance was dismal in 2019, has some important catalysts to watch out for this year.

from RTT - Biotech https://ift.tt/2ZNKfk8
via IFTTT

Rising Geopolitical Tensions May Lead To Pullback On Wall Street

The major U.S. index futures are currently pointing to a sharply lower opening on Friday, with stocks likely to give back some ground following the rally seen over the course of the previous session.

from RTT - Market Analysis https://ift.tt/2ZUAK2U
via IFTTT

FiveStar Gourmet Recalls Two Snack Products

FiveStar Gourmet Foods is recalling two fresh produce snack products - protein pack and avocado toast, for possible Listeria monocytogenes contamination, the U.S. Food and Drug Administration or FDA said in a statement. The recall involves MiniMeal2Go-ProteinPack 8.25oz and MiniMeal2Go- AvocadoToast 6.75oz. The decision was taken following a notification from egg supplier Almark Foods.

from RTT - Biotech https://ift.tt/2ttJkJS
via IFTTT

Esperion (ESPR) Almost Doubled In 2019, What Awaits The Stock In 2020?

Shares of Esperion Therapeutics Inc. (ESPR), which closed at a new 52-week high of $61.34, have gained more than 60% over the last 3 months.

from RTT - Biotech https://ift.tt/2ZKjhdc
via IFTTT

Equillium (EQ) Well Equipped For 2020...

After a disappointing performance in 2019, shares of Equillium Inc. (EQ) seem to have started the year on a right note - gaining over 20% on Thursday - the first day of trading in 2020.

from RTT - Biotech https://ift.tt/2ZOl4Ol
via IFTTT

IDEAYA (IDYA) Braces For Busy Year - MUM's The Word, Stock Up Over 20%

IDEAYA Biosciences Inc. (IDYA), an oncology-focused precision medicine company, has a couple of clinical trial catalysts lined up for this year.

from RTT - Biotech https://ift.tt/39zDR4F
via IFTTT

DRRX Plunges On Psoriasis Trial Data, INCY Fails GRAVITAS-301 Test, AGRX Abuzz

Today's Daily Dose brings you news about Agile Therapeutics' strengthened commercial leadership team; DURECT's decision to discontinue the development of DUR-928 in mild to moderate plaque psoriasis; Novan's disappointing molluscum contagiosum trial results; Incyte's acute graft-versus-host disease trial results and Innate Pharma's regulatory catalyst that drove the stock to a new 52-week high.

from RTT - Biotech https://ift.tt/36qrOVu
via IFTTT

Upward Momentum May Lead To Continued Strength In 2020

The major U.S. index futures are pointing to a higher opening on Thursday, with stocks likely to extend the strong upward move seen last year.

from RTT - Market Analysis https://ift.tt/2Fclx3z
via IFTTT

Aurobindo Pharma Recalls Certain Depressive Disorder Medication

Aurobindo Pharma USA, Inc. recalled a certain lot of depressive disorder medication Mirtazapine in the form of tablets for a label error on declared strength, the U.S. Food and Drug Administration or FDA said in a statement. The East Windsor, New Jersey-based generic pharma company is recalling Mirtazapine tablets of 7.5 mg and 15 mg strengths that are packaged in 500 count bottles.

from RTT - Biotech https://ift.tt/39wU8ay
via IFTTT

Sol-Gel Technologies Gets Makeover, Stock More Than Doubled In A Month

Shares of Sol-Gel Technologies Ltd. (SLGL) have more than doubled over the last one month, thanks to positive data from its acne trials.

from RTT - Biotech https://ift.tt/39zlyfI
via IFTTT

US election, Brexit and China to sway the markets in 2020

Investors expect a strong year but the presidential race and trade wars could spring nasty surprises

After profiting from strong markets in 2019, investors are expecting 2020 to bring further rising asset prices and lively merger activity. But Brexit, the US presidential election and the US trade war with China could all spring nasty surprises over the next 12 months and give the long-running bull market a jolt.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/37sFSxO